RAPAFLO
- Product NDC
- 0023-6142
- 11-digit product format
- 000236142
- Labeler code
- 0023
- Product ID
- 0023-6142_6cba0207-6e74-431e-9298-710b5fc592d4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- silodosin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Allergan, Inc.
- Application
- NDA022206
- Marketing category
- NDA
- Marketing start
- 2009-03-23
- Marketing end
- 0000-00-00
- Substance
- SILODOSIN
- Active strength
- 8 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0023-6142 | RAPAFLO (SILODOSIN) CAPSULE [ALLERGAN, INC.] | 7 | Legacy NDC | 20250516_da0314f6-b1d6-44ee-8b1e-f763dbb8613f.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0023-6142-30 | 00023614230 | 30 CAPSULE in 1 BOTTLE, UNIT-DOSE (0023-6142-30) | 30 capsule | 2009-03-23 | 0000-00-00 | No | No | Current |
| 0023-6142-90 | 00023614290 | 90 CAPSULE in 1 BOTTLE, UNIT-DOSE (0023-6142-90) | 90 capsule | 2009-03-23 | 2022-12-31 | No | No | Current |